Manwell, Laurie A <br/><br/>
FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.  [electronic resource] 

 -  Pharmacology, biochemistry, and behavior  Nov 2009 
 - 154-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5177 
<br/><br/><label>Standard No.: </label>10.1016/j.pbb.2009.08.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--antagonists & inhibitors<br/>Animals<br/>Benzamides--administration & dosage<br/>Cannabinoid Receptor Modulators--metabolism<br/>Carbamates--administration & dosage<br/>Choice Behavior--drug effects<br/>Conditioning, Psychological<br/>Dietary Sucrose--administration & dosage<br/>Extinction, Psychological--drug effects<br/>Female<br/>Injections, Intraperitoneal<br/>Injections, Subcutaneous<br/>Male<br/>Morphine--adverse effects<br/>Morphine Dependence--drug therapy<br/>Naloxone--therapeutic use<br/>Narcotic Antagonists--therapeutic use<br/>Narcotics--adverse effects<br/>Piperidines--administration & dosage<br/>Pyrazoles--administration & dosage<br/>Rats<br/>Rats, Long-Evans<br/>Rats, Sprague-Dawley<br/>Receptor, Cannabinoid, CB1--agonists<br/>Reinforcement Schedule<br/>Rimonabant<br/>Species Specificity<br/>Substance Withdrawal Syndrome